BioProcessors Raises $10 Million

BioProcessors Corp., a Woburn, Mass.-based developer of micro-engineered solutions for biopharmaceutical process development applications, has raised $10.01 million in Series C funding at a post-money valuation of approximately $68 million. Life Sciences Partners was joined by return backers Healthcare Ventures, HLM Venture Partners, New Science Ventures and Oxford Bioscience Partners. This is the company's second Series C tranche, and it has now raised $54.5 million in total VC funding since 2001.